<DOC>
	<DOCNO>NCT01712763</DOCNO>
	<brief_summary>The long acting GnRH antagonist degarelix test treatment woman endometriosis recurrence compare classical GnRH analog treatment . Pain symptom disappearance disease free time follow-up outcome establish medical treatment best endometriosis recurrence treatment .</brief_summary>
	<brief_title>Degarelix Treatment Endometriosis Recurrence</brief_title>
	<detailed_description>Endometriosis chronic disease affect 5-10 % woman reproductive age , show recurrence surgery least 20-50 % 5 year follow-up . The long acting GnRH antagonist degarelix , flare-up effect opposite GnRH agonist strongly suppress LH secretion thecal cell activity may show good effect endometrial implant GnRH agonist .</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Goserelin</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<criteria>woman affect endometriosis show recurrence pain symptom previous surgery endometriosis presence systemic disease</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Endometriosis</keyword>
	<keyword>long act GnRH antagonist</keyword>
	<keyword>Degarelix</keyword>
	<keyword>Recurrence</keyword>
	<keyword>Pelvic Pain</keyword>
</DOC>